Search research articles
Contact Us
Filters
Showing results (641-650 of 683) with videos related to
Page
of 69
Sort By:
Clinical and Translational Science
|
October 24, 2023
AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double-blind, efficacy, and safety study
Jacob M van Laar, Alejhandra Lei, Mary Safy-Khan, et al.
Clinical Therapeutics
|
October 28, 2017
Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl
Lowell Anthony, Claire Ervin, Pablo Lapuerta, et al.
Neuroimage. Clinical
|
January 23, 2015
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study
M Pagani, F De Carli, S Morbelli, et al.
Gerontology
|
November 30, 2022
Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study
Jonathan K L Mak, Maria Eriksdotter, Martin Annetorp, et al.
The Journal of Physical Chemistry Letters
|
August 2, 2017
Real-Time Elucidation of Catalytic Pathways in CO Hydrogenation on Ru
J LaRue, O Krejčí, L Yu, et al.
Skin Health and Disease
|
June 5, 2023
Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
Johan Mattsson, Elisabeth Israelsson, Karin Björhall, et al.
The New England Journal of Medicine
|
February 11, 2011
Everolimus for advanced pancreatic neuroendocrine tumors
James C Yao, Manisha H Shah, Tetsuhide Ito, et al.
Scientific Reports
|
July 20, 2022
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
Angela Martinez-Monleon, Hanna Kryh Öberg, Jennie Gaarder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2016
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome
Matthew H Kulke, Dieter Hörsch, Martyn E Caplin, et al.
Journal of Hepatocellular Carcinoma
|
October 29, 2024
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
Ruth Plummer, Alastair Greystoke, Gregory Naylor, et al.
Page
of 69
Search research articles
Search
Showing results (641-650 of 683) with videos related to
Sort By:
Page
of 69
Clinical and Translational Science
|
October 24, 2023
AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double-blind, efficacy, and safety study
Jacob M van Laar, Alejhandra Lei, Mary Safy-Khan, et al.
Clinical Therapeutics
|
October 28, 2017
Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl
Lowell Anthony, Claire Ervin, Pablo Lapuerta, et al.
Neuroimage. Clinical
|
January 23, 2015
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study
M Pagani, F De Carli, S Morbelli, et al.
Gerontology
|
November 30, 2022
Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study
Jonathan K L Mak, Maria Eriksdotter, Martin Annetorp, et al.
The Journal of Physical Chemistry Letters
|
August 2, 2017
Real-Time Elucidation of Catalytic Pathways in CO Hydrogenation on Ru
J LaRue, O Krejčí, L Yu, et al.
Skin Health and Disease
|
June 5, 2023
Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
Johan Mattsson, Elisabeth Israelsson, Karin Björhall, et al.
The New England Journal of Medicine
|
February 11, 2011
Everolimus for advanced pancreatic neuroendocrine tumors
James C Yao, Manisha H Shah, Tetsuhide Ito, et al.
Scientific Reports
|
July 20, 2022
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
Angela Martinez-Monleon, Hanna Kryh Öberg, Jennie Gaarder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2016
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome
Matthew H Kulke, Dieter Hörsch, Martyn E Caplin, et al.
Journal of Hepatocellular Carcinoma
|
October 29, 2024
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
Ruth Plummer, Alastair Greystoke, Gregory Naylor, et al.
Page
of 69